New Bismuth Germanate Oxide Nanoparticle Material for Biolabel Applications in Medicine

Figure 2

BGO nanoparticles preparations after protein reagent treatment and later centrifugation. (1) BGO nanoparticles treated with BSA in the presence of EDC in 10 mM Tris HCl. (2) BGO nanoparticles treated with BSA in the absence of EDC in 10 mM Tris HCl. (3) BGO nanoparticles treated with EDC and without BSA in 10 mM Tris HCl. (4) BGO nanoparticles in 10 mM Tris HCl without BSA and EDC.